Log In
BCIQ
Print this Print this
 

ALD1910

  Manage Alerts
Collapse Summary General Information
Company Alder BioPharmaceuticals Inc.
Description mAb targeting pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38)
Molecular Target Pituitary adenylate cyclase-activating peptide-38 (PACAP-38)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationMigraine
Indication DetailsPrevent migraine
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today